P. Murphy

发表

Pituitary plasmacytoma—a rare presentation of multiple myeloma

J. Cryan, J. Quinn, C. Comerford, 2018, Irish Journal of Medical Science (1971 -).

CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study.

S. Naicker, A. Ryan, M. Cahill, 2019, Blood advances.

Transfusion requirements in patients with COVID‐19

R. Morgan, J. Quinn, G. Curley, 2020, European Journal of Haematology.

Early-onset chronic lymphocytic leukaemia in a young man with Cowden syndrome

J. Quinn, P. Murphy, C. Molloy, 2016, Annals of Hematology.

Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome

M. Gleeson, P. Murphy, R. Desmond, 2009, British journal of haematology.

Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera.

H. Hassan, P. Murphy, N. Ahmed, 2002, Leukemia research.

Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiency

J. Quinn, R. Swords, P. Murphy, 2006, Annals of Hematology.

Identification and Treatment of Anaemia in Older Patients

P. Murphy, R. Hutchinson, 1994, Drugs & aging.

Factor V Leiden and venous thromboembolism.

P. Murphy, 2004, Annals of internal medicine.

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma

C. Thompson, J. Quinn, P. Murphy, 2019, Experimental Hematology & Oncology.

A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy

E. Verburgh, H. Enright, J. Quinn, 2014, Leukemia & lymphoma.

Slow responses to standard dose rituximab in immune thrombocytopenic purpura

M. Gleeson, P. Murphy, K. Kelly, 2009, Haematologica.

Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)

R. Swords, P. Murphy, R. O'donnell, 2004, American journal of hematology.

Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha

S. Langabeer, P. Murphy, S. McPherson, 2011, Annals of Hematology.

A diagnostic dilemma in AL(L)PS

M. Keogan, J. Quinn, O. Smith, 2014, Annals of Hematology.

CML clonal evolution with resistance to single agent imatinib therapy.

J. Goldman, J. Quinn, R. Swords, 2005, Clinical and laboratory haematology.

Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisis

S. Langabeer, J. Quinn, C. Comerford, 2017, Journal of Clinical Pathology.

CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression

P. Murphy, J. O'donnell, D. McCabe, 2004, Leukemia.

Another case of myelodysplasia with monosomy 7 following fludarabine‐based chemotherapy

P. Murphy, S. Mitra, D. O'Donghaile, 2006, American journal of hematology.

Successful induction of molecular remission with single‐agent anti‐CD33 antibody (gemtuzumab ozogamicin) in chemotherapy‐refractory relapse of acute myeloid leukaemia post‐BMT

M. Lawlor, R. Swords, K. Molloy, 2004, European journal of haematology.

Low risk of central venous thrombosis with nontunnelled central venous catheters.

P. Murphy, N. O'connor, 2001, Clinical and laboratory haematology.

Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma

J. Laubach, P. Richardson, A. Yee, 2022, American journal of hematology.

Pure red cell aplasia complicating chronic lymphocytic leukemia: rapid response to high-dose methylprednisolone and rituximab

J. Quinn, P. Murphy, P. Thornton, 2013, Leukemia & lymphoma.

Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia

S. Langabeer, K. Haslam, J. Quinn, 2018, Case reports in hematology.

Improvement in antithrombotic management in atrial fibrillation also requires effective INR control

P. Murphy, M. Casey, 2001, Postgraduate medical journal.

Venetoclax for chronic lymphocytic leukemia associated immune thrombocytopenia following recovery from progressive multifocal leukoencephalopathy.

F. Brett, J. Quinn, P. Murphy, 2020, Leukemia research.

Relationship between cell surface expression of CD38 and of vascular endothelial growth factor in B-cell chronic lymphocytic leukemia.

P. Murphy, D. McCabe, K. O'Regan, 2004, Leukemia research.

ALFA‐INTERFERON IN A CASE OF HYPEREOSINOPHILIC SYNDROME

P. Murphy, D. Fennelly, M. Stuart, 1990 .

Alfa-interferon in a case of hypereosinophilic syndrome.

P. Murphy, D. Fennelly, M. Stuart, 1990, British journal of haematology.

From a direct oral anticoagulant to warfarin: reasons why patients switch

J. Quinn, P. Murphy, P. Thornton, 2018, Irish Journal of Medical Science (1971 -).

A 5-day: the favourable way?

E. Verburgh, H. Enright, J. Quinn, 2014, Annals of Hematology.

Interleukin-4 and tumour necrosis factor-alpha produce non isotype specific partial differentiation of peripheral blood B-cells in myeloma.

P. Murphy, R. Hutchinson, 1998, Leukemia & lymphoma.

Electrocardiography before treatment with anthracycline-based chemotherapy in a tertiary hospital in the Republic of Ireland.

P. Murphy, D. Parfrey, Niamh O'Connor Byrne, 2021, Journal of electrocardiology.

Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring

S. Langabeer, Kanthi Perera, J. Krawczyk, 2012, Case reports in hematology.

J. Quinn, P. Murphy, 2005 .

B19 parvovirus infection causing aplastic crisis in 3 out of 5 family members with hereditary spherocytosis

P. Murphy, J. O’Donnell, 1990, Irish journal of medical science.

Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment

X. Leleu, C. Kyriakou, B. Arnould, 2017, Blood Cancer Journal.

Sustained molecular response with nilotinib in imatinib-intolerant chronic myeloid leukaemia with an e19a2 BCR-ABL1 fusion.

S. Langabeer, P. Murphy, M. Crampe, 2016, Hematology/oncology and stem cell therapy.

Severe factor X deficiency and successful pregnancy

R. Chazal, J. Konje, P. Murphy, 1994, British journal of obstetrics and gynaecology.

VEGF in Hematopoietic Malignancy

J. Quinn, P. Murphy, 2004 .

Adult attention deficit hyperactivity disorder and driving - risk, medication and fitness to drive.

J. Quinn, P. Murphy, J. Burke, 2017, Irish medical journal.

Rivaroxaban May Increase Platelet Activation In Vivo via Thromboxane A2.

S. Grace, J. Quinn, P. Murphy, 2019, Circulation research.

Role of synthetic retinoic acid derivatives in Chronic Lymphocytic Leukemia and Multiple Myeloma

P. Murphy, S. Napoletano, Ayman T. Saeed, 2013, BMC Proceedings.

Platelet hyporeactivity in active myeloma.

D. Kenny, Niamh M. Cooke, J. Quinn, 2014, Thrombosis research.

Autologous stem cell transplantation in myeloma: the St James’s Hospital experience, 1997–2003

H. Enright, R. Swords, S. McCann, 2005, Irish journal of medical science.

Bortezomib‐induced reversible posterior leucoencephalopathy syndrome

P. Murphy, K. Kelly, R. Kalachand, 2008, British journal of haematology.

Targeting of the Wnt/β-Catenin Pathway in Chronic Lymphocytic Leukaemia may adversely affect CTLA-4 expression and function

G. Lynch, P. Murphy, Stephen M. Bergin, 2018 .

Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn’s disease after immunosuppressive therapy

M. Leader, S. Patchett, J. Quinn, 2007, Journal of Clinical Pathology.

Progressive multifocal leukoencephalopathy developing in a fludarabine naïve patient with chronic lymphocytic leukemia

M. Ooi, P. Kelly, P. O’Gorman, 2009, International journal of general medicine.

Induction Treatment in Transplant-eligible Multiple Myeloma

J. Quinn, C. Comerford, P. Murphy, 2021, HemaSphere.

Remission of transfusion-dependent myelodysplastic syndrome in association with respiratory tract infection

J. Quinn, P. Murphy, M. Fay, 2005, Annals of Hematology.

Chronic myeloid leukemia and acromegaly in POEMS syndrome.

H. Hassan, P. Murphy, N. Ahmed, 2002, Leukemia research.

Red blood cells from COVID-19 patients suffer from increased oxidative stress and may have increased lactate influx

G. Healy, J. Quinn, P. Murphy, 2022, Blood research.

Hodgkin lymphoma in a patient with chronic lymphocytic leukaemia--a rare presentation of Richter's transformation.

M. Leader, J. Quinn, P. Murphy, 2015, Irish medical journal.

A MUTATION IN THE POLYADENYLATION SIGNAL OF THE α2 GLOBIN GENE (AATAA→AATA–) AS A CAUSE OF α THALASSAEMIA IN ASIAN INDIANS

D. Higgs, G. Hall, P. Murphy, 1994, British journal of haematology.

Lymphoma associated bone marrow necrosis with raised anticardiolipin antibody.

J. Wood, P. Murphy, A. Liddicoat, 1998, Journal of clinical pathology.

Central retinal venous occlusion with co-existent thrombotic thrombocytopenic purpura and antiphospholipid syndrome

P. Murphy, P. Rao, 2003, British Journal of Ophthalmology.

Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis

J. Quinn, R. Swords, P. Murphy, 2004, The Annals of pharmacotherapy.

Emergence of Bruton's tyrosine kinase‐negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemia

T. Marafioti, M. Leader, M. Catherwood, 2017, European journal of haematology.

Molecular responses in e19a2 BCR-ABL1 chronic myeloid leukemia

S. Langabeer, J. Krawczyk, E. Conneally, 2020, Leukemia research reports.

Aplastic anaemia preceding acute lymphoblastic leukaemia in an adult with isolated deletion of chromosome 9q.

P. Murphy, K. Kelly, 2008, Leukemia research.

Autoimmune haemolytic anaemia associated with ulcerative colitis.

R. Cunney, P. Murphy, A. Nolan, 1996, Irish medical journal.

Anemia and red blood cell abnormalities in COVID-19

J. Quinn, P. Murphy, S. Glavey, 2021, Leukemia & lymphoma.

Liver injury during rivaroxaban treatment in a patient with AL amyloidosis

J. Quinn, P. Murphy, M. Lavin, 2021, European journal of clinical pharmacology.

Dialysis‐dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma

M. Denton, P. O'kelly, C. Magee, 2014, British journal of haematology.

Psychometric Performance Of The EORTC Quality-Of-Life Core Questionnaire (QLQ-C30) and QLQ-Multiple Myeloma (QLQ-MY20) In Relapsed/Refractory Multiple Myeloma (RRMM)

A. Bottomley, X. Leleu, C. Kyriakou, 2013 .

Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis

P. Murphy, J. O’Donnell, 1990, Irish Journal of Medical Science.

Risk factors for highly unstable response to oral anticoagulation

P. Murphy, 2005, British journal of haematology.

Audit of patients on oral anticoagulants with International normalized ratios of eight or above.

P. Murphy, K. Abrams, M. Casey, 1998, Clinical and Laboratory Haematology.

Refractory ITP in a patient with Kabuki syndrome: response to low-dose rituximab

J. Quinn, P. Murphy, B. Kerr, 2017, International journal of hematology.

IRRADIATION OF TRANSFUSED PRODUCTS IN PREVENTION OF THIRD PARTY MEDIATED GVHD AND GRAFT REJECTION

P. Murphy, K. Gelsthorpe, D. Ashton, 1993, British Journal of Haematology.

Pediatric‐type follicular lymphoma—Complete metabolic remission with radiation therapy

R. Flavin, B. Doyle, J. Quinn, 2019, Hematological oncology.

A Phase II Multi-Center Study of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RsqVD) in Newly Diagnosed Multiple Myeloma - Ctrial-IE (ICORG) 13-17 Study

J. Laubach, P. Richardson, M. Coyne, 2016 .

Serum erythropoietin at diagnosis in low grade myelodysplastic syndrome correlates with both red cell zinc protoporphyrin and serum lactic dehydrogenase (LDH) and may reflect severity of ineffective erythropoiesis

P. Murphy, K. Breen, J. Slabý, 2009, Leukemia & lymphoma.

Identification and Treatment of Anaemia in Older Patients

P. Murphy, R. Hutchinson, 1994, Drugs & aging.

Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.

J. Quinn, R. Swords, P. Murphy, 2006, Clinical and laboratory haematology.

Thalidomide induced impotence in male hematology patients: a common but ignored complication?

P. Murphy, J. O’Donnell, 2007, Haematologica.